We have recently identified a novel p53 pro-survival signaling pathway involving upregulation of p53 target genes or DNA damage checkpoint genes, which can influence the balance between cell death and arrest/senescence in a p53 dependent DNA damage response. We have identified the RhoE gene as a novel transcriptional target of p53 and DNA damage. We found that DNA damage triggers actin depolymerization, resulting in stress-fiber disassembly through p53-dependent RhoE activation. RhoE is a recent addition of the small GTPases superfamily and has the strongest homology to RhoA, B, and C. Despite this high homology, RhoE has several unusual properties which distinguish it from the other Rho proteins. Unlike other Rho proteins, RhoE seems to be only Rho family protein transcriptionally responsive to DNA damage that can induce loss of actin stress fibers. We hypothesize that RhoE protein are essential for survival of cancer cells with wtp53 by suppressing the activity of proapoptotic proteins while enhancing the function of prosurvival proteins in response to the exposure of DNA damage. The main goal of this proposal is to understand the unusual roles of a small GTPase, RhoE, as a novel target gene of p53-dependent DNA damage and to translate our basic understanding of the cell survival function of RhoE into apoptosis for human cancer cells including breast cancer cells. Although the biological role of RhoE in DNA damage response pathway has not yet been defined, our preliminary data demonstrating transactivation of the RhoE gene by p53-dependent DNA damage, its potential role as a key organizer of the actin cytoskeleton, and its exceptional role in DNA damage-induced cell survival are intriguing to us. Accumulating evidence suggest that an aberrant signaling through Rho proteins is closely associated with various steps of tumorigenesis and carcinogenesis. In this application, a combination of biochemical and genetic approaches will be used to (i) delineate the functions of RhoE in p53 dependent cellular outcomes and DNA damage stress response;(ii) Identify and characterize RhoE Interacting partners, which will define a molecular pathway that affects RhoE-mediated cell survival and p53-dependent cell death in response to genotoxic stress;iii) determine if ROCK 1 is an essential upstream regulator for JNK-mediated cell death signaling;and (iv) define the role of RhoE in DNA damage checkpoint signaling and cell survival signaling using in mouse knockout approach.

Public Health Relevance

The main goal of this proposal is to understand the unusual roles of a small GTPase, RhoE, as a novel target gene of p53-dependent DNA damage and to translate our basic understanding of the cell survival function of RhoE into apoptosis in response to therapeutics in human cancer cells.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Okano, Paul
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Zhu, Zehua; Todorova, Kristina; Lee, Kevin K et al. (2014) Small GTPase RhoE/Rnd3 is a critical regulator of Notch1 signaling. Cancer Res 74:2082-93
Gurkar, Aditi U; Chu, Kiki; Raj, Lakshmi et al. (2013) Identification of ROCK1 kinase as a critical regulator of Beclin1-mediated autophagy during metabolic stress. Nat Commun 4:2189
Namba, Takushi; Tian, Fang; Chu, Kiki et al. (2013) CDIP1-BAP31 complex transduces apoptotic signals from endoplasmic reticulum to mitochondria under endoplasmic reticulum stress. Cell Rep 5:331-9
Chun, Kwang-Hoon; Araki, Kazushi; Jee, Yuna et al. (2012) Regulation of glucose transport by ROCK1 differs from that of ROCK2 and is controlled by actin polymerization. Endocrinology 153:1649-62
Huang, Hu; Kong, Dong; Byun, Kyung Hee et al. (2012) Rho-kinase regulates energy balance by targeting hypothalamic leptin receptor signaling. Nat Neurosci 15:1391-8
Raj, Lakshmi; Ide, Takao; Gurkar, Aditi U et al. (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475:231-4
Mandinova, Anna; Lee, Sam W (2011) The p53 pathway as a target in cancer therapeutics: obstacles and promise. Sci Transl Med 3:64rv1
Kim, Hyung-Gu; Hwang, So-Young; Aaronson, Stuart A et al. (2011) DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation. J Biol Chem 286:17672-81
Zhao, Bo; Benson, Erica K; Qiao, Ruifang et al. (2009) Cellular senescence and organismal ageing in the absence of p21(CIP1/WAF1) in ku80(-/-) mice. EMBO Rep 10:71-8
Lee, Dae Ho; Shi, Jianjian; Jeoung, Nam Ho et al. (2009) Targeted disruption of ROCK1 causes insulin resistance in vivo. J Biol Chem 284:11776-80

Showing the most recent 10 out of 15 publications